"Disease Susceptibility" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases.
| Descriptor ID |
D004198
|
| MeSH Number(s) |
C23.550.291.687 G07.100.250
|
| Concept/Terms |
Disease Susceptibility- Disease Susceptibility
- Diathesis
- Diatheses
- Susceptibility, Disease
- Disease Susceptibilities
- Susceptibilities, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Susceptibility".
Below are MeSH descriptors whose meaning is more specific than "Disease Susceptibility".
This graph shows the total number of publications written about "Disease Susceptibility" by people in this website by year, and whether "Disease Susceptibility" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 3 | 3 |
| 1998 | 0 | 3 | 3 |
| 2000 | 0 | 3 | 3 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 7 | 7 |
| 2004 | 0 | 2 | 2 |
| 2005 | 1 | 2 | 3 |
| 2006 | 1 | 6 | 7 |
| 2007 | 3 | 5 | 8 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 5 | 5 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 3 | 3 |
| 2012 | 0 | 6 | 6 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 5 | 6 |
| 2016 | 1 | 4 | 5 |
| 2017 | 4 | 5 | 9 |
| 2018 | 1 | 2 | 3 |
| 2019 | 6 | 6 | 12 |
| 2020 | 3 | 3 | 6 |
| 2021 | 0 | 5 | 5 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Susceptibility" by people in Profiles.
-
Complement downregulation promotes an inflammatory signature that renders colorectal cancer susceptible to immunotherapy. J Immunother Cancer. 2022 09; 10(9).
-
Targeted Therapy for BRAF Mutant Brain Tumors. Curr Treat Options Oncol. 2021 10 06; 22(11):105.
-
Aortic valve disease in diabetes: Molecular mechanisms and novel therapies. J Cell Mol Med. 2021 10; 25(20):9483-9495.
-
Elevated Fibronectin Levels in Profibrotic CD14+ Monocytes and CD14+ Macrophages in Systemic Sclerosis. Front Immunol. 2021; 12:642891.
-
Modelling and predicting the spatio-temporal spread of COVID-19, associated deaths and impact of key risk factors in England. Sci Rep. 2021 03 08; 11(1):5378.
-
Promising vulnerability markers of substance use and misuse: A review of human neurobehavioral studies. Neuropharmacology. 2021 04 01; 187:108500.
-
Key Players and Biomarkers of the Adaptive Immune System in the Pathogenesis of Sarcoidosis. Int J Mol Sci. 2020 Oct 07; 21(19).
-
Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses. RMD Open. 2020 09; 6(2).
-
Rhinitis 2020: A?practice parameter update. J Allergy Clin Immunol. 2020 10; 146(4):721-767.
-
Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management. Metab Syndr Relat Disord. 2020 05; 18(4):173-175.